General Medicine and Primary Care

Episodes 1-15 of 15

• 

  RestartResume

  Updates in Major Depressive Disorder with Insomnia

  RestartResume

  Updates in Major Depressive Disorder with Insomnia

  CME/CE

  Updates in Major Depressive Disorder with Insomnia

  0.50 credits

  • 

    

    Michael E. Thase, MD

  • 

    

    Andrew Krystal, MD

  0.50 credits

• 

  RestartResume

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  RestartResume

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  CME/CE

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  0.25 credits

  • 

    

    Christoph U. Correll, MD

  • 

    

    Jonathan M. Meyer

  0.25 credits

• 

  RestartResume

  Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study

  RestartResume

  Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study

  Psychiatry and Mental Health

  Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study

  • 

    

    Christoph U. Correll, MD

• 

  RestartResume

  Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4

  RestartResume

  Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4

  Psychiatry and Mental Health

  Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4

  • 

    

    Jonathan M. Meyer, MD

• 

  MinuteCE®

  AF and VTE: Global Considerations in the Evolving Space of Real-World Data

  1.00 credit 10 episodes

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 credit 10 episodes

• 

  RestartResume

  Setting the Stage of Real-World Data vs RCT

  RestartResume

  Setting the Stage of Real-World Data vs RCT

  MinuteCE®

  Setting the Stage of Real-World Data vs RCT

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  1.00 program credit

• 

  RestartResume

  Trade off: Ischemic/Thrombotic vs Bleeding  

  RestartResume

  Trade off: Ischemic/Thrombotic vs Bleeding  

  MinuteCE®

  Trade off: Ischemic/Thrombotic vs Bleeding  

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  1.00 program credit

• 

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations

  MinuteCE®

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations

  1.00 program credit

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  How Do We Translate Real-World AF Data Into Everyday Clinical Practice?

  RestartResume

  How Do We Translate Real-World AF Data Into Everyday Clinical Practice?

  MinuteCE®

  How Do We Translate Real-World AF Data Into Everyday Clinical Practice?

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  Patient Case Study: Elderly

  RestartResume

  Patient Case Study: Elderly

  MinuteCE®

  Patient Case Study: Elderly

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  Patient Case Study: Obesity

  RestartResume

  Patient Case Study: Obesity

  MinuteCE®

  Patient Case Study: Obesity

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations  

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations  

  MinuteCE®

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations  

  1.00 program credit

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit

• 

  RestartResume

  How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?

  RestartResume

  How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?

  MinuteCE®

  How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?

  1.00 program credit

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit

• 

  RestartResume

  Patient Case Study: Cancer-Associated Thrombosis

  RestartResume

  Patient Case Study: Cancer-Associated Thrombosis

  MinuteCE®

  Patient Case Study: Cancer-Associated Thrombosis

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit

• 

  RestartResume

  Patient Case Study: Obesity and VTE

  RestartResume

  Patient Case Study: Obesity and VTE

  MinuteCE®

  Patient Case Study: Obesity and VTE

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit